Merck, Bristol-Myers agree to settle Keytruda patent suit

Jan 20 (Reuters) - Merck & Co said it agreed to

enter into a settlement and license agreement with Bristol-Myers

Squibb Co and Ono Pharmaceutical Co Ltd to

resolve a patent litigation related to its cancer drug,

Keytruda.

Read more